Microbial evaluation of some non-sterile pharmaceutical preparations commonly used in the Egyptian market

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorGad G.F.M.
dc.contributor.authorAly R.A.I.
dc.contributor.authorAshour M.S.E.-D.
dc.contributor.otherMicrobiology Department
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherMinia University
dc.contributor.otherMinia
dc.contributor.otherEgypt; Microbiology Department
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherModern Science and Arts University
dc.contributor.otherCairo
dc.contributor.otherEgypt
dc.date.accessioned2020-01-25T19:58:31Z
dc.date.available2020-01-25T19:58:31Z
dc.date.issued2011
dc.descriptionScopus
dc.description.abstractPurpose: To determine the type and incidence of predominant microorganisms in certain non-sterile pharmaceuticals immediately after collection and one year later. Methods: All pharmaceutical samples were subjected to the following examinations: total bacterial count and presence of microbial pathogens, using conventional techniques. Attempts were also made to identify the isolates. The bioburden rate of some of the syrups and oral drops after storage for 0, 6 and 12 months were evaluated in order to assess the effect of storage on microbial contamination level. Results: Microbial load varied among the pharmaceutical preparations with the highest microbial load in suspensions and the lowest in tablets. Bacterial counts ranged from 10 to more than 103 CFU per ml or g. The bacterial count at 6 and 12 months were significantly different from that at 0 month (p < 0.05). The isolated organisms were either of human flora types, essentially Gram-positive bacteria, or airborne fungi. Conclusion: The isolated organisms were either of human flora types, principally, Gram-positive bacteria, or air-borne fungi and the stored preparations lack an effective preservation. Several measures, including equipment automation, monitoring programs and post-marketing surveillanceare required to reduce the level of microbial contamination of non-sterile pharmaceutical products. � Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City.en_US
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=18800156708&tip=sid&clean=0
dc.identifier.doihttps://doi.org/10.4314/tjpr.v10i4.9
dc.identifier.doiPubMed ID :
dc.identifier.issn15965996
dc.identifier.otherhttps://doi.org/10.4314/tjpr.v10i4.9
dc.identifier.otherPubMed ID :
dc.identifier.urihttps://t.ly/9LJbn
dc.language.isoEnglishen_US
dc.publisherUniversity of Beninen_US
dc.relation.ispartofseriesTropical Journal of Pharmaceutical Research
dc.relation.ispartofseries10
dc.subjectBacteriaen_US
dc.subjectFungien_US
dc.subjectMicrobial contaminationen_US
dc.subjectNon-sterile pharmaceuticalsen_US
dc.subjectnose dropsen_US
dc.subjectairborne fungusen_US
dc.subjectarticleen_US
dc.subjectbacterial counten_US
dc.subjectbacterium isolationen_US
dc.subjectcontrolled studyen_US
dc.subjectdrug contaminationen_US
dc.subjectdrug marketingen_US
dc.subjectdrug storageen_US
dc.subjectEgypten_US
dc.subjectfungus isolationen_US
dc.subjectGram positive bacteriumen_US
dc.subjectmicrobial contaminationen_US
dc.subjectmicrobial identificationen_US
dc.subjectmicroorganism detectionen_US
dc.subjectnonhumanen_US
dc.subjectoral dropsen_US
dc.subjectsuspensionen_US
dc.subjectsyrupen_US
dc.subjecttableten_US
dc.titleMicrobial evaluation of some non-sterile pharmaceutical preparations commonly used in the Egyptian marketen_US
dc.typeArticleen_US
dcterms.isReferencedByCoker, M., An assessment of microbial contamination during drug manufacturing in Ibadan, Nigeria (2005) Eur J Scientific Res, 7, pp. 19-23; Shaikh, D., Jamshed, T.A., Shaikh, R., Microbial contamination of pharmaceutical preparations (1988) Pak J Pharm Sci, 1, pp. 61-66; Parker, M.S., Microbiological contamination and preservation of pharmaceutical preparations (2000) Pharmaceutics: The science of dosage from design, p. 220. , In:, 2nd edn. China, Churchill Livingstone; Denyer, S.P., Hodges, N.A., Gorman, S.P., Hugo, W., Russell, A., (2004) Pharmaceutical Microbiology, pp. 220+240. , 7th edn. London, U. K., Blackwell Science; Manu-Tawiah, W., Brescia, B.A., Montgomery, E.R., Setting threshold limits for the significance of objectionable microorganisms in oral pharmaceutical products (2001) PDA J Pharm Sci Technol, 55, pp. 171-175; Bloomfield, S.F., Control of microbial contamination in non sterile pharmaceuticals, cosmetics and toiletries (1988) Microbial quality assurance in pharmaceuticals, cosmetics and toiletries, p. 150. , In:, 1st edn. Chichester, Ellis Horwood Limited and Halsted Press; Akerele, J.O., Godwin, U.C., Aspects of microbial contamination of tablets dispensed in hospitals and community pharmacies in Benin City, Nigeria (2002) Trop J Pharm Res, 1, pp. 23-28; (1993) British Pharmacopoeia, 1, pp. 195-200. , Appendix XVI BA; de la Rosa, M.C., Mosso, M.A., Garcia, M.L., Plaza, C., Resistance to the antimicrobial agents of bacteria isolated from non-sterile pharmaceuticals (1993) J Appl Bacteriol, 74, pp. 570-577; Jawetz, E., (1987) Review on Medicinal Microbiology, pp. 170+180. , 17th ed. Norwalk, CT, Appleton & Larpe; Fernandez, G.S., Genis, M.Y., The formation of aflatoxins in different types of starches for pharmaceutical use (1979) Pharm Acta Helv, 54, pp. 78-85; Okunlola, A., Adewoyin, B.A., Odeku, O.A., Evaluation of Pharmaceutical and Microbial Qualities of Some Herbal Medicinal Products in South Western Nigeria (2007) Trop J Pharm Res, 6, pp. 661-670; Beys, L., Hoest, B., Investigation for Staphylococci in foods, dietetic products and oral drugs (1971) Rev J Food Protec, 25, pp. 26-33; Lund, B.M., Foodborne disease due to Clostridium and Bacillus species (1990) Lancet, 336, pp. 982-986; Friedel, R.R., Cundell, A.M., The application of water activity measurement to the microbiological attributes testing of non-sterile over-thecounter drug products (1998) Pharmacopeial Forum, 24, pp. 6087-6090; Craven, D.E., Moody, B., Connoly, M.G., Kollisch, N.R., Stottmeier, K.D., McCabe, W.R., Pseudobacteraemia caused by povidone-iodine antiseptics contaminated by Pseudomonas aeurginosa (1981) New Engl J Med, 305, pp. 621-623
dcterms.sourceScopus

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
avatar_scholar_256.png
Size:
6.31 KB
Format:
Portable Network Graphics
Description:
Loading...
Thumbnail Image
Name:
69556-Article Text-146250-1-10-20110914.pdf
Size:
84.33 KB
Format:
Adobe Portable Document Format
Description: